Occurrence of vitiligo in a patient with ankylosing spondylitis receiving adalimumab

被引:8
|
作者
Toussirot, E. [1 ,2 ,3 ,4 ]
Salard, D. [5 ]
Algros, M. -P. [6 ]
Aubin, F. [7 ,8 ]
机构
[1] CHRU, Ctr Invest Clin Biotherapie, Pole Rech, Inserm CBT 506, F-25000 Besancon, France
[2] Hop Jean Minjoz, CHRU, Pole PACTE, F-25000 Besancon, France
[3] Univ Franche Comte, Dept Univ Therapeut, F-25000 Besancon, France
[4] Univ Franche Comte, UPRES EA Agents Pathogenes & Inflammat 4266, SFR FED 4234, F-25000 Besancon, France
[5] Ctr Hosp, Serv Med 1, F-25300 Pontarlier, France
[6] Hop Jean Minjoz, CHRU, Serv Anat Pathol, F-25030 Besancon, France
[7] Hop Jean Minjoz, CHRU, Serv Dermatol, F-25030 Besancon, France
[8] Univ Franche Comte, Equipe Accueil EA3181, SFR FED 4234, F-25000 Besancon, France
来源
关键词
NECROSIS-FACTOR-ALPHA;
D O I
10.1016/j.annder.2013.09.158
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:801 / 802
页数:2
相关论文
共 50 条
  • [21] Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab
    Éric Toussirot
    Romain Charollais
    François Aubin
    European Journal of Dermatology, 2016, 26 : 406 - 408
  • [22] Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab
    Toussirot, Eric
    Charollais, Romain
    Aubin, Francois
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (04) : 406 - 408
  • [23] Psychotic Depression Induced by Adalimumab in a Patient with Ankylosing Spondylitis: A Case Report
    Erbay, Lale Gonenir
    Sarioglu, Fatma Kartal
    Darilmaz, Cengiz
    Kartalci, Sukru
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2018, 8 (04): : 204 - 207
  • [24] An Overview of Adalimumab Therapy for Ankylosing Spondylitis
    Sukhanova, Anna M.
    Gilavian, Mariam A.
    Melnik, Elizaveta V.
    Shikh, Evgenia V.
    Petukhov, Alexey E.
    Gegechkori, Vladimir I.
    Dementev, Sergey P.
    Vlasov, Alexander M.
    Ramenskaya, Galina V.
    CURRENT RHEUMATOLOGY REVIEWS, 2024, 20 (05) : 501 - 513
  • [25] Efficacy and safety of adalimumab in ankylosing spondylitis
    Mounach, Aziza
    El Maghraoui, Abdellah
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2014, 6 : 83 - 90
  • [26] ANKYLOSING SPONDYLITIS: ADALIMUMAB URUGUAYAN EXPERIENCE
    Palleiro, D.
    Spangenberg, E.
    Corbacho, I
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S76 - S76
  • [27] Reversible Heart Failure in a Patient Receiving Etanercept for Ankylosing Spondylitis
    Castro Rocha, Francisco Airton
    Silva, Francisco Saraiva, Jr.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (02) : 81 - 82
  • [28] Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report
    Azevedo, V. F.
    Pietrovski, C. F.
    de Almeida Santos, M., Jr.
    REUMATISMO, 2010, 62 (04) : 283 - 285
  • [29] Adalimumab-induced leukocytoclastic vasculitis in a patient with ankylosing spondylitis: A case report
    Khabbazi, Alireza
    Hajialilo, Mehrzad
    Tekantapeh, Sepideh Tahsini
    Tabrizi, Sahar Farshchi
    Salehi, Alireza
    CLINICAL CASE REPORTS, 2024, 12 (08):
  • [30] Lobular capillary hemangioma in a patient with ankylosing spondylitis using adalimumab: an exuberant presentation
    Silva, Thadeu Santos
    Martins Guimaraes, Carlos Leonardo
    Xavier, Isabela Pimenta
    Pedreira de Almeida Rego, Vitoria Regina
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (06) : 751 - 753